Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis
Mucormycosis, a secondary fungal infection, gained much attention in the ongoing COVID-19 pandemic. This deadly infection has a high all-cause mortality rate and imposes a significant economic, epidemiological, and humanistic burden on the patients and healthcare system. Evidence from the published...
Guardado en:
Autores principales: | Salman Hussain, Abanoub Riad, Ambrish Singh, Jitka Klugarová, Benny Antony, Hasanul Banna, Miloslav Klugar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9d61247f58a4c9ca9fedacc70a33eb8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
por: Junyan Qu, et al.
Publicado: (2021) -
Rhino-orbito-cerebral Mucormycosis: Pictorial Review
por: Vivek Pai, et al.
Publicado: (2021) -
Mucormycosis in Hematologic Malignancies: Clinical Follow-Up and Treatment Results
por: Nagehan Didem Sarı, et al.
Publicado: (2021) -
Inhibition of EGFR Signaling Protects from Mucormycosis
por: Tonya N. Watkins, et al.
Publicado: (2018) -
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
por: F. Yuan, et al.
Publicado: (2021)